Topol: AI biomarker models can predict Alzheimer's onset decades early
Dr. Eric Topol · 7 More Healthy Years: What We Can Learn from Super Agers · May 27, 2025 · at 9:30
Dr. Eric Topol, founder of the Scripps Research Translational Institute, describes how AI models analyze blood biomarkers like P-Tau 217 to predict cognitive decline timeline.
0:00 / 0:30exact quote · 30.5s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“For example, with Alzheimer's, you get a P-Tau, two 17. It's modifiable by lifestyle. You check it again in, you know, six months or a year. Now you have two data points, and you can say, you know, with all the other data that's available, when you're gonna see 18 years from now, 12 years, four years, mild cognitive impairment, unless these steps are taken. This was fully dependent on AI, on models that can, you know, just take all this data.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Dr. Eric Topol
Topol: Personalized vaccines are curing pancreatic and kidney cancers
“So vaccines now are capable Of cures of pancreatic cancer, kidney cancer, with these personalized vaccines using the proteins of the person's tumor.”
Topol: FDA-approved Alzheimer's drugs do not work and are very risky
“The Alzheimer's drugs, which don't really work, and they're very risky”
Topol: Mass screening detects only 14% of cancers despite massive costs
“We only pick up 14% of cancers from that mass screening, which costs over hundreds of billions of dollars a year.”
Topol: Risk-partitioned care can add seven healthy years to life
“There should be a reboot new standard of care based on intelligent partitioning of risk. Seven years more of healthspan free of the major three diseases.”
Topol: Age reversal therapies like senolytics remain unproven in humans
“Where you get reversing of aging, so you keep people healthier body-wide, and that's where we see all this remarkable investments in companies like Altos and with reprogramming, Senolytics, and a long list. But they're really focused on a monumental task, whic…”
Topol: Immune system therapies will eventually eliminate cancer deaths
“And so, you know, whether it's antibody drug conjugates, a tumor infiltrating lymphocytes, and all these different ways, it's hard to imagine that in the future, we're gonna lose people with cancer, Because of being able to bring your immune system to the high…”